CERMELLI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 13.917
AS - Asia 6.636
EU - Europa 5.798
SA - Sud America 1.027
AF - Africa 176
Continente sconosciuto - Info sul continente non disponibili 140
OC - Oceania 28
Totale 27.722
Nazione #
US - Stati Uniti d'America 13.506
SG - Singapore 1.982
CN - Cina 1.829
GB - Regno Unito 1.749
IT - Italia 1.419
HK - Hong Kong 754
BR - Brasile 744
VN - Vietnam 694
SE - Svezia 531
DE - Germania 450
FR - Francia 323
FI - Finlandia 287
RU - Federazione Russa 267
KR - Corea 257
BD - Bangladesh 246
UA - Ucraina 229
TR - Turchia 226
IN - India 153
CA - Canada 150
MX - Messico 116
AR - Argentina 94
BG - Bulgaria 86
ID - Indonesia 85
JP - Giappone 72
ZA - Sudafrica 67
IQ - Iraq 65
BE - Belgio 62
NL - Olanda 53
IE - Irlanda 49
EC - Ecuador 46
PL - Polonia 45
CO - Colombia 38
ES - Italia 38
RO - Romania 36
CL - Cile 31
PK - Pakistan 29
AT - Austria 28
VE - Venezuela 28
LT - Lituania 26
AE - Emirati Arabi Uniti 25
AU - Australia 24
MA - Marocco 24
CZ - Repubblica Ceca 23
MY - Malesia 22
CR - Costa Rica 21
KE - Kenya 21
HN - Honduras 20
TH - Thailandia 20
UZ - Uzbekistan 20
TT - Trinidad e Tobago 19
IL - Israele 18
PY - Paraguay 17
EG - Egitto 16
IR - Iran 15
PH - Filippine 15
SA - Arabia Saudita 15
HU - Ungheria 14
PE - Perù 14
PT - Portogallo 14
TW - Taiwan 14
JO - Giordania 13
SV - El Salvador 13
CH - Svizzera 12
GP - Guadalupe 12
GT - Guatemala 12
TN - Tunisia 12
DO - Repubblica Dominicana 11
NP - Nepal 10
PR - Porto Rico 10
AZ - Azerbaigian 9
KG - Kirghizistan 8
PA - Panama 8
DK - Danimarca 7
KZ - Kazakistan 7
OM - Oman 7
BO - Bolivia 6
DZ - Algeria 6
GR - Grecia 6
JM - Giamaica 6
SN - Senegal 6
UY - Uruguay 6
CI - Costa d'Avorio 5
ET - Etiopia 5
EU - Europa 5
LV - Lettonia 5
SC - Seychelles 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
CW - ???statistics.table.value.countryCode.CW??? 4
HR - Croazia 4
MT - Malta 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RS - Serbia 4
SI - Slovenia 4
AO - Angola 3
BB - Barbados 3
BH - Bahrain 3
GE - Georgia 3
Totale 27.545
Città #
Ashburn 2.061
Singapore 1.237
Santa Clara 1.177
Southend 1.117
San Jose 752
Hong Kong 748
Chandler 681
Fairfield 622
Hefei 619
Council Bluffs 495
Jacksonville 407
Houston 396
Ann Arbor 377
Woodbridge 351
Beijing 313
Los Angeles 291
Dearborn 283
Nyköping 278
Modena 248
London 244
Wilmington 239
Seattle 238
New York 228
Ho Chi Minh City 227
Seoul 211
Cambridge 202
Helsinki 201
Chicago 193
Hanoi 161
Dallas 151
The Dalles 136
Milan 129
São Paulo 118
Izmir 99
Princeton 94
Moscow 85
Sofia 84
Buffalo 83
Lauterbourg 83
Orem 76
San Diego 70
Redwood City 67
Eugene 66
Salt Lake City 59
Shanghai 59
Munich 58
Boardman 57
Tokyo 57
Columbus 54
Rome 52
Mexico City 51
Jakarta 50
Bologna 49
Bremen 49
Des Moines 49
Denver 42
Phoenix 42
Brussels 40
Da Nang 39
Toronto 39
Atlanta 38
Manchester 37
Warsaw 37
Elk Grove Village 36
Jeju City 36
Johannesburg 36
Tampa 36
Brooklyn 34
Frankfurt am Main 34
Montreal 34
San Francisco 33
Wuhan 33
Naples 30
Chennai 29
Dublin 29
Kent 29
Miami 29
Nuremberg 29
Fremont 28
North Bergen 27
Falls Church 26
Palermo 26
Philadelphia 26
Guangzhou 25
Nanjing 25
Parma 25
Baghdad 24
Washington 23
Boston 21
Haiphong 21
Poplar 21
Reggio Emilia 21
Stockholm 21
Paris 20
Timisoara 20
Belo Horizonte 19
Tashkent 19
Ankara 18
Biên Hòa 18
Brasília 18
Totale 17.875
Nome #
In vitro virucidal efficacy of a dry steam disinfection system against Human Coronavirus, Human Influenza Virus, and Echovirus 499
Herpes simplex virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals. 471
EFFECT OF EUCALYPTUS ESSENTIAL OIL ON RESPIRATORY BACTERIA AND VIRUSES 451
A transmissible cytotoxic activity isolated from a patient with brain ischemia causes microglial cell activation and dysfunction 440
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections 436
Human herpesvirus-6 dysregulates monocyte-mediated anticryptococcal defences 429
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 426
Influence of hyaluronic acid on bacterial and fungal species, including clinically relevant opportunistic pathogens. 423
Antiviral activity of Hyaluronic Acid 422
Candida albicans biofilm can retain and release Human Herpes simplex virus type 1 in vitro 409
Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study 401
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 401
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 390
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 381
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 371
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 370
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 366
Growth of human herpesvirus 6 in HepG2 cells 356
Herpes simplex virus type 1 dysregulates anti-fungal defenses preventing monocyte activation and downregulating toll-like receptor-2 352
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 352
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 346
A New Phenotype in Candida-Epithelial Cell Interaction Distinguishes Colonization- versus Vulvovaginal Candidiasis- Associated Strains 338
Selenite inhibition of Coxsackie virus B5 replication: implications on the etiology of Keshan disease. 337
Herpes Simplex Virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals and UVA1 laser treatment 337
In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid. 333
Apoptosis and inflammatory response in human astrocytes are induced by a transmissible cytotoxic agent of neurological origin 328
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 328
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 328
Cell culture isolation of a transmissible cytotoxicity from a human sample of cerebrospinal fluid 323
Indagine sulla eziologia di infezioni a prevalente trasmissione alimentare. 321
In vitro interactions between viruses and Candida biofilm. 321
Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. 318
Human pathogenic viruses are retained in and released by Candida albicans biofilm in vitro 318
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 314
CANDIDA ALBICANS HYPHAL DEVELOPMENT AND BIOFILM FORMATION/PERSISTENCE ARE DIFFERENTIALLY AFFECTED BY MOUTHWASHES DEPENDING UPON THEIR COMPOSITION. 314
Gene expression profiling on monocytes displaying Herpes Simplex virus 1-induced dysregulation of antifungal defences. 305
Viruses and Multiple Sclerosis 300
Screening of the antibacterial effects of a variety of essential oils on the microrganims responsible for respiratory infections 300
Beretti F., Cermelli C., Cenacchi V., Orsi C., Blasi E., Portolani M. 295
Antiviral activity of propolis 291
Epstein-Barr virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus infection and central nervous system disorders 289
Detection of Antibodies Directed against Human Herpesvirus 6 U94/REP in Sera of Patients Affected by Multiple Sclerosis 284
“Microbiologia medica” Volume 3 della nuova edizione italiana sulla settima edizione di Prescott, Harley and Klein’s “Microbiology” . 284
Growth of Epstein-Barr Virus on monocytes and its effects on immune functions. 282
Applicazioni del microarray proteico nella diagnosi diretta per la sierotipizzazione di agenti patogeni 281
Neurotoxic effects of coronavirus: Potential implications in Alzheimer's onset and progression 274
Wide spectrum activity of a high molecular weight Hyaluronic Acid. 273
Case report: primary infection by human herpesvirus 6 variant a with the onset of myelitis. 272
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 267
Antiviral and virucide activity of propolis 266
Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections 264
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 264
Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7. 259
Human herpesvirus 6 (HHV-6) U94/REP protein inhibits betaherpesvirus replication 258
Encephaloradiculomyelitis associated to HHV-7 and CMV co-infection in immunocompetent host 258
MICROARRAY PROTEICI NELLA DIAGNOSI DIRETTA: SIEROTIPIZZAZIONE DI AGENTI PATOGENI 257
Alterazione delle difese monocito-mediate nei confronti di miceti in presenza di virus erpetici 257
Human herpesvirus-7 DNA in cerebrospinal fluid. 253
APPLICAZIONE DEI MICROARRAY PROTEICI NELLA DIAGNOSTICA AVANZATA DI PATOLOGIEMICROBICHE E VIRALI 249
Alterazione delle difese monocito-mediate nei confronti di Cryptococcus neoformans in presenza dell’Herpesvirus umano 6 247
In vitro evaluation of virucidal activity of epoxy/clay nanocomposites 246
Diagnostica delle gastroenteriti virali 244
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 244
Comparison of culture and immunoassay for detection of Escherichia coli O157 in raw minced meat and hamburger 243
Evaluation of a vero cell toxicity test to detect EHEC infection 241
HSV-1 induces macrophage activation and dysregulation in monocytes 237
Human herpesvirus-6 dysregulates monocyte-ediated anticryptococcal defences. 235
Synthesis and antiviral activity of new benzothiadiazine dioxide derivates 234
Cytotoxicity and probable mechanism of action of sulphimidazole 231
SYNTHESIS AND BIOLOGICAL-ACTIVITY OF NEW HETEROCYCLIC STRUCTURES - [1,3]THIAZINO[2,3-I]PURINE, THIAZOLO[3,2-C] ]1,2,3]TRIAZOLO[4,5-E]PYRIMIDINE AND [1,2,3]TRIAZOLO [4', 5'/4,5] PYRIMIDO[6,1-B][1,3]THIAZINE 230
The protein “mycoarray”: a novel immunoassay for the serological diagnosis of primitive invasive mycoses 230
HSV-1 induces dysregulation of monocyte anticandida functions 226
Funghi e virus nelle infezioni miste: storie di sinergie e di contrasti 223
SYNTHESIS AND BIOLOGICAL-ACTIVITY OF PYRIMIDO[2,1-B][1,3]THIAZINE, [1,3]THIAZINO[3,2-A]PURINE AND [1,2,3]TRIAZOLO[4,5-D][1,3]THIAZINO[3,2-A]PYRIMIDINE DERIVATIVES AND THIAZOLE ANALOGS 220
Establishment of an in vitro model to study co-infection of vaginal epithelium by Candida albicans and Herpes Simplex Virus 2 218
In vitro virucidal activity of active food packaging based on monoglycerides against a Human Coronavirus and other viruses 214
Relation between psychoneuroendocrine profile in stressful conditions and antibodies to herpesvirus 6 and 7 214
SENDAI VIRUS AND HERPES-VIRUS TYPE-1 INDUCE APOPTOSIS IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS 204
Candida albicans as a Trailblazer for Herpes Simplex Virus-2 Infection Against an In Vitro Reconstituted Human Vaginal Epithelium 201
recurrent bilateral optic neuritis associated with active infection by Human Herpesvirus 6B 197
In vitro evaluation of the virucide activity of nanostructured antimicrobial coatings for personal protective equipments 189
Revealing Commercial Epoxy Resins’ Antimicrobial Activity: A Combined Chemical–Physical, Mechanical, and Biological Study 185
Detection of Epstein-Barr virus DNA in cerebrospinal fluid from immunocompetent individuals with brain disorders 178
The long-standing history of Corynebacterium parvum, immunity, and viruses 178
Antiviral and antiproliferative activity in vitro of some new benzimidazole derivatives 177
Prevalenza degli herpesvirus nel tessuto epatico da soggetti con epatite C 176
An outbreak of infantile aseptic meningitis caused by Echo 30 175
VIRUCIDAL ACTIVITY OF EPOXY RESINS 173
Epstein-Barr virus DNA in cerebrospinal fluid from an immunocompetent man with herpes simplex virus encephalitis. 168
Development of a 3D in vitro epithelial model to investigate host-pathogen interactions during Candida albicans and Herpes Simplex Virus 2 mono- and co-infections in a simulated vaginal environment 166
Virucide activity of nanocomposites based on resin included clays for sanization of highly touched surfaces 153
A three year follow-up of low grade squamous intraepithelial lesions: Persistence of lesions is significantly influenced by the presence of high risk papillomaviruses 150
Initial geno-phenotypic characterization of colon mycobiota from healthy donors 149
IgG antibodies to papillomavirus genus-antigens in adult men with cancer of the urinary bladder 145
Zein-based nanostructured coatings: A green approach to enhance virucidal efficacy of protective face masks 144
Effectiveness of the antibody-derived killer peptide on Candida albicans biofilm 144
High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection 140
Sierodiagnosi di infezioni a trasmissione verticale mediante microarray proteico 137
Valutazione in vitro dell’efficacia antivirale di coatings antimicrobici nanostrutturati per dispositivi di protezione individuale 137
COVID-19 and Facial Masks: How, Where, When, and Why 116
Totale 27.591
Categoria #
all - tutte 96.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.070 0 0 0 0 43 106 93 87 146 107 295 193
2022/20232.023 203 208 174 181 292 277 29 196 222 47 115 79
2023/20241.337 41 73 100 80 253 136 199 132 52 46 97 128
2024/20254.622 136 85 119 295 785 608 390 295 449 229 558 673
2025/20269.289 662 475 751 1.246 1.407 612 1.075 488 877 847 488 361
2026/20273.199 361 603 766 1.218 251 0 0 0 0 0 0 0
Totale 27.722